SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-012524
Filing Date
2024-02-08
Accepted
2024-02-08 06:10:14
Documents
2
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1551
2 EX-24 kytx-ex24.htm EX-24 10674
  Complete submission text file 0000950170-24-012524.txt   13728
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Issuer) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KYVERNA THERAPEUTICS, INC. 5980 HORTON ST., SUITE 550 EMERYVILLE CA 94608
Business Address
Liapis Stephen Constantine (Reporting) CIK: 0002009951 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41947 | Film No.: 24606735